Technology Platforms

Veryan currently has two key patented or patent pending assets:

  1. Proprietary Stent Platform: Veryan’s CE Marked flagship product
    • The BioMimics 3D vascular biomimetic stent is currently indicated for the treatment of the superficial femoral and proximal popliteal (“fem-pop” or “femoropopliteal”) arteries
    • The design of the BioMimics 3D stent is built on the principles underlying the latest generation of Nitinol (nickel-titanium alloy) stent technology
    • The 3D helical shape provides enhanced mechanical performance and biomechanical compatibility compared to straight, laser-cut Nitinol stents
    • The helical geometry of the BioMimics 3D stent mimics the actual shape of the human vascular system and promotes a more natural swirling blood flow
    • The delivery system is a simple to use “pin & pull” system that requires no change to standard stenting procedure
  2. 3D Helical Stent Design: Veryan’s intellectual property around such helical stent design, which can be applied to existing stent platforms
    • Can be applied to any laser-cut Nitinol stent platform, without additional manufacturing costs, to transform a straight stent into a three dimensional (“3D”) helical configuration with improved performance